What to know about federal court ruling blocking mailing of widely used abortion pill
Summary
A federal appeals court has blocked the mailing of mifepristone, a widely used abortion pill, requiring it to be given only in person at clinics. This ruling affects all states and challenges federal Food and Drug Administration (FDA) rules, and it is expected to be appealed to the U.S. Supreme Court.Key Facts
- The 5th U.S. Circuit Court of Appeals ruled unanimously to stop mailing mifepristone prescriptions.
- The ruling was made by a court based in New Orleans and overturns FDA regulations allowing mailed abortion pills.
- Louisiana’s Attorney General sued the FDA, claiming the mailed pills violate the state’s abortion ban.
- Judge Kyle Duncan, appointed by President Donald Trump, wrote the decision.
- The ruling applies nationwide, even in states without abortion restrictions.
- Mifepristone has been approved since 2000 as a safe and effective drug to end early pregnancies.
- Most abortions in the U.S. involve pills, and about 25% are prescribed through telehealth (remote doctor visits).
- Some states have passed laws to protect providers who mail abortion pills, but these “shield laws” are under legal challenge.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.